Evidence map›Paper›PMID 31333607›Full record

ArticleFrontiers in microbiology2019

Nationwide Molecular Epidemiology of Measles Virus in Japan Between 2008 and 2017.

Fumio Seki, Masahiro Miyoshi, Tatsuya Ikeda, Haruna Nishijima, Miwako Saikusa, Masae Itamochi, Hiroko Minagawa, Takako Kurata, Rei Ootomo, Jumboku Kajiwara and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 1 country.

Fumio SekiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Masahiro MiyoshiHokkaido Institute of Public Health, Sapporo, Japan.
Tatsuya IkedaYamagata Prefectural Institute of Public Health, Yamagata, Japan.
Haruna NishijimaChiba Prefectural Institute of Public Health, Chiba, Japan.
Miwako SaikusaYokohama City Institute of Public Health, Yokohama, Japan.
Masae ItamochiToyama Institute of Health, Imizu, Japan.
Hiroko MinagawaAichi Prefectural Institute of Public Health, Nagoya, Japan.
Takako KurataOsaka Institute of Public Health, Osaka, Japan.
Rei OotomoTottori Prefectural Institute of Public Health and Environmental Science, Tottori, Japan.
Jumboku KajiwaraFukuoka Institute of Health and Environmental Sciences, Dazaifu, Japan.
Takashi KatoOkinawa Prefectural Institute of Health and Environment, Uruma, Japan.
Katsuhiro KomaseInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
Keiko Tanaka-TayaInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
Tomimasa SunagawaInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kazunori OishiInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
Nobuhiko OkabeKawasaki City Institute for Public Health, Kawasaki, Japan.
Hirokazu KimuraGraduate School of Health Science, Gunma Paz University, Takasaki, Japan.
Shigeru SugaDepartment of Pediatrics, National Mie Hospital, Tsu, Japan.
Kunihisa KozawaGraduate School of Medicine, Yokohama City University, Yokohama, Japan.
Noriyuki OtsukiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshio MoriDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Komei ShirabeYamaguchi Prefectural Institute of Public Health and Environment, Yamaguchi, Japan.
Makoto TakedaDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Measles Virus Surveillance Group of Japan
Technical Support Team for Measles Control in Japan
National Institute of Infectious Diseases · JPAichi Prefectural Government · JPChiba Prefectural Institute of Public Health · JPFukuoka Institute of Health and Environmental Sciences · JPGumma Paz College · JPHokkaido Institute of Public Health · JPNational Mie Hospital · JPOkinawa Prefectural Institute of Health and Environment · JPOsaka Prefectural Institute of Public Health · JPToyama Institute of Health · JPYamagata Prefectural Institute of Public Health · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genotyping evidence that supports the interruption of endemic measles virus (MV) transmission is one of the essential criteria to be verified in achieving measles elimination. In Japan since 2014, MV genotype analyses have been performed for most of the measles cases in prefectural public health institutes nationwide. With this strong molecular epidemiological data, Japan was verified to have eliminated measles in March, 2015. However, even in the postelimination era, sporadic cases and small outbreaks of measles have been detected repeatedly in Japan. This study investigated the nationwide molecular epidemiology of MV between 2008 and 2017. The 891 strains in the total period between 2008 and 2017 belonged to seven genotypes (D5, D4, D9, H1, G3, B3, and D8) and 124 different MV sequence variants, based on the 450-nucleotide sequence region of the N gene (N450). The 311 MV strains in the postelimination era between 2015 and 2017 were classified into 1, 7, 8, and 32 different N450 sequence variants in D9, H1, B3, and D8 genotypes, respectively. Analysis of the detection period of the individual N450 sequence variants showed that the majority of MV strains were detected only for a short period. However, MV strains, MVs/Osaka.JPN/29.15/ [D8] and MVi/Hulu Langat.MYS/26.11/ [D8], which are named strains designated by World Health Organization (WHO), have been detected in many cases over 2 or 3 years between 2015 and 2017. The WHO-named strains have circulated worldwide, causing outbreaks in many countries. Epidemiological investigation revealed repeated importation of these WHO-named strains into Japan. To demonstrate the elimination status (interruption of endemic transmission) in situations with repeated importation of the same strains is challenging. Nevertheless, the detailed sequence analysis of individual MV strains and chronological analysis of these strains provided sufficient evidence to show that Japan has still maintained its measles elimination status in 2017.

Indexed as

eliminationgenotypeJapanmeasles virusmolecular epidemiology

Identifiers

PMID31333607
PMCPMC6620789
OpenAlexW2955006315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.